Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database (road031, 2023)

被引：0
|
作者：
Harigai, M.
机构：
来源：
MODERN RHEUMATOLOGY | 2024年 / 34卷 / 02期
关键词：
D O I：
10.1093/mr/road048
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 437
页数：1
相关论文
共 50 条
  • [1] Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs: Evaluation of data from a Japanese claims database
    Harigai, Masayoshi
    Fujii, Takao
    Sakai, Ryoko
    Igarashi, Ataru
    Shoji, Ayako
    Yamaguchi, Hiroko
    Iwasaki, Katsuhiko
    Makishima, Misako
    Yoshida, Amika
    Okada, Norihiro
    Yamashita, Katsuhisa
    Kawahito, Yutaka
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 287 - 296
  • [2] Risk of Hospitalized Infections in Older Elderly Rheumatoid Arthritis Patients Treated with Biological/Targeted Synthetic DMARDs: Evaluation Using Data from a Japanese Claims Database
    Harigai, Masayoshi
    Fujii, Takao
    Sakai, Ryoko
    Igarashi, Ataru
    Shoji, Ayako
    Yamaguchi, Hiroko
    Iwasaki, Katsuhiko
    Makishima, Misako
    Yoshida, Amika
    Okada, Norihiro
    Yamashita, Katsuhisa
    Kawahito, Yutaka
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2747 - 2749
  • [3] Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs
    Singh, Namrata
    Gold, Laura S.
    Lee, Jiha
    Wysham, Katherine D.
    Andrews, James S.
    Makris, Una E.
    England, Bryant R.
    George, Michael D.
    Baker, Joshua F.
    Jarvik, Jeffrey
    Heagerty, Patrick J.
    Singh, Siddharth
    ARTHRITIS CARE & RESEARCH, 2024, 76 (05) : 627 - 635
  • [4] Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
    Ichinose, Kunihiro
    Shimizu, Toshimasa
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Tamai, Mami
    Nakamura, Hideki
    Sato, Shuntaro
    Origuchi, Tomoki
    Kawakami, Atsushi
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [5] PERSISTENCE WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - A RETROSPECTIVE DATABASE STUDY IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Mahlich, J.
    Kameda, H.
    Sruamsiri, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 440 - 440
  • [6] Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort study
    Tong, Xinning
    Shen, Chin-Yao
    Jeon, Ha-Lim
    Li, Yihua
    Shin, Ju-Young
    Chan, Shirley C. W.
    Yiu, Kai Hang
    Pratt, Nicole L.
    Ward, Michael
    Lau, Chak Sing
    Wong, Ian C. K.
    Li, Xue
    Lai, Edward Chia-Cheng
    JOURNAL OF INTERNAL MEDICINE, 2023, 294 (03) : 314 - 325
  • [7] Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Freites Nunez, Dalifer
    Leon, Leticia
    Redondo, Marta
    Vadillo Font, Cristina
    Lois, Pia
    Mucientes Ruiz, Arkaitz
    Rodriguez-Rodriguez, Luis
    Fernandez Gutierrez, Benjamin
    Jover Jover, Juan Angel
    Abasolo Alcazar, Lydia
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Pawar, Ajinkya
    Desai, Rishi J.
    He, Mengdong
    Bessette, Lily
    Kim, Seoyoung C.
    ACR OPEN RHEUMATOLOGY, 2021, 3 (08) : 531 - 539
  • [9] Risk of malignant lymphoma in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs and methotrexate
    Inose, Ryo
    Hosomi, Kouichi
    Takahashi, Katsuyuki
    Yokoyama, Satoshi
    Takada, Mitsutaka
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (02) : 63 - 72
  • [10] Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Baker, Matthew C.
    Liu, Yuhan
    Lu, Rong
    Lin, Janice
    Melehani, Jason
    Robinson, William H.
    JAMA NETWORK OPEN, 2023, 6 (03)
12345